Published in Hepatol Res on June 01, 2003
Non-HFE haemochromatosis. World J Gastroenterol (2007) 1.37
Compound overload of copper and iron in patients with Wilson's disease. Med Mol Morphol (2006) 0.97
Recent advances in understanding haemochromatosis: a transition state. J Med Genet (2004) 0.88
Measurement of serum hepcidin-25 levels as a potential test for diagnosing hemochromatosis and related disorders. J Gastroenterol (2010) 0.81
STING recognition of cytoplasmic DNA instigates cellular defense. Mol Cell (2013) 2.18
Two novel mutations, L490R and V561X, of the transferrin receptor 2 gene in Japanese patients with hemochromatosis. Haematologica (2005) 2.12
Patients with chronic hepatitis C achieving a sustained virological response to peginterferon and ribavirin therapy recover from impaired hepcidin secretion. J Hepatol (2008) 1.85
A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C: a multicenter, prospective, randomized, controlled trial in Japan. J Gastroenterol (2004) 1.83
Long term effects of phlebotomy on biochemical and histological parameters of chronic hepatitis C. Am J Gastroenterol (2002) 1.63
Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese. PLoS One (2012) 1.56
Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma. Clin Gastroenterol Hepatol (2011) 1.56
Current state of Wilson disease patients in central Japan. Intern Med (2010) 1.45
RAGE control of diabetic nephropathy in a mouse model: effects of RAGE gene disruption and administration of low-molecular weight heparin. Diabetes (2006) 1.43
Septic shock is associated with receptor for advanced glycation end products ligation of LPS. J Immunol (2011) 1.30
Immunohistochemical evaluation of oxidative stress markers in chronic hepatitis C. Antioxid Redox Signal (2004) 1.03
Comparison of outcomes between patients with alcoholic cirrhosis and those with hepatitis C virus-related cirrhosis. J Gastroenterol Hepatol (2009) 1.02
Clinical and pathological progression of non-alcoholic steatohepatitis to hepatocellular carcinoma. Hepatol Res (2012) 0.96
Clinical significance of intrahepatic interleukin-8 in chronic hepatitis C patients. Hepatol Res (2002) 0.92
RAGE in diabetic nephropathy. Curr Mol Med (2007) 0.90
Influence of viral load and genotype in the progression of Hepatitis B-associated liver cirrhosis to hepatocellular carcinoma. Liver Int (2005) 0.88
Effect of vitamin E on serum aminotransferase and thioredoxin levels in patients with viral hepatitis C. Free Radic Res (2003) 0.87
Potential of the international scoring system for the diagnosis of Wilson disease to differentiate Japanese patients who need anti-copper treatment. Hepatol Res (2011) 0.87
Short-chain aldehyde-derived ligands for RAGE and their actions on endothelial cells. Diabetes Res Clin Pract (2007) 0.86
Blockade of diabetic vascular injury by controlling of AGE-RAGE system. Curr Drug Targets (2005) 0.85
In vitro inhibition of glycogen-degrading enzymes and glycosidases by six-membered sugar mimics and their evaluation in cell cultures. Bioorg Med Chem (2008) 0.85
Ursodeoxycholic acid induces glutathione synthesis through activation of PI3K/Akt pathway in HepG2 cells. Biochem Pharmacol (2008) 0.84
A Japanese family with ferroportin disease caused by a novel mutation of SLC40A1 gene: hyperferritinemia associated with a relatively low transferrin saturation of iron. Intern Med (2005) 0.84
Three patients with middle-age-onset hemochromatosis caused by novel mutations in the hemojuvelin gene. J Hepatol (2005) 0.83
Low molecular weight heparin suppresses receptor for advanced glycation end products-mediated expression of malignant phenotype in human fibrosarcoma cells. Cancer Sci (2013) 0.83
Determination of ferritin and hemosiderin iron in patients with normal iron stores and iron overload by serum ferritin kinetics. Nagoya J Med Sci (2012) 0.83
Additional effect of low iron diet on iron reduction therapy by phlebotomy for chronic hepatitis C. Hepatogastroenterology (2005) 0.82
Biochemical staging of the chronic hepatic lesions of Wilson disease. Nagoya J Med Sci (2014) 0.82
Long term follow-up of a group of chronic hepatitis C patients treated with anti-inflammatory drugs following initial interferon therapy. Hepatol Res (2002) 0.82
Receptor for advanced glycation end products is a promising target of diabetic nephropathy. Ann N Y Acad Sci (2005) 0.81
High prevalence of fulminant hepatic failure among patients with mutant alleles for truncation of ATP7B in Wilson's disease. Scand J Gastroenterol (2010) 0.81
Measurement of serum hepcidin-25 levels as a potential test for diagnosing hemochromatosis and related disorders. J Gastroenterol (2010) 0.81
Increase in P-glycoprotein accompanied by activation of protein kinase Calpha and NF-kappaB p65 in the livers of rats with streptozotocin-induced diabetes. Biochim Biophys Acta (2008) 0.81
Identification of a novel mutation in the HAMP gene that causes non-detectable hepcidin molecules in a Japanese male patient with juvenile hemochromatosis. Blood Cells Mol Dis (2012) 0.80
Clinicopathological study of Japanese patients with genetic iron overload syndromes. Pathol Int (2012) 0.80
Copper- and iron-rich matrices in hepatocellular lipofuscin particles of a young male patient: diagnostic ultrastructures for Wilson disease. Ultrastruct Pathol (2006) 0.80
Potentiation of vasoconstrictor response and inhibition of endothelium-dependent vasorelaxation by gallic acid in rat aorta. Planta Med (2002) 0.79
Identification of a novel 2026G-->C mutation of the MRP2 gene in a Japanese patient with Dubin-Johnson syndrome. J Hum Genet (2003) 0.78
Increasing and decreasing phases of ferritin and hemosiderin iron determined by serum ferritin kinetics. Nagoya J Med Sci (2013) 0.78
Adsorption of bile acid by chitosan salts prepared with cinnamic acid and analogue compounds. J Biomater Sci Polym Ed (2006) 0.78
Effects of catechins on vascular tone in rat thoracic aorta with endothelium. Life Sci (2002) 0.77
An analysis of risk factors for developing Hepatocellular carcinoma in a group of Hepatitis C patients with stage 3 fibrosis following interferon therapy. Cancer Inform (2008) 0.77
Mutational analysis of the MRP2 gene and long-term follow-up of Dubin-Johnson syndrome in Japan. J Gastroenterol (2005) 0.77
Hemojuvelin hemochromatosis receiving iron chelation therapy with deferasirox: improvement of liver disease activity, cardiac and hematological function. Eur J Haematol (2011) 0.77
Hepcidin expression in iron overload diseases is variably modulated by circulating factors. PLoS One (2012) 0.77
A male patient with ferroportin disease B and a female patient with iron overload similar to ferroportin disease B. Clin J Gastroenterol (2014) 0.77
Risk factors for survival and the development of hepatocellular carcinoma in patients with primary biliary cirrhosis. Intern Med (2013) 0.76
Structure-activity relationships of flavonoids as potential inhibitors of glycogen phosphorylase. J Agric Food Chem (2008) 0.76
Wilson's disease masquerading as nonalcoholic steatohepatitis. N Am J Med Sci (2009) 0.76
Reduction of MDR3 mRNA levels by forskolin in Chang liver cells. Anticancer Res (2003) 0.75
[Iron reduction therapy by phlebotomy for chronic hepatitis C]. Nihon Rinsho (2011) 0.75
[AGE-RAGE system]. Nihon Rinsho (2016) 0.75
[Non-alcoholic steatohepatitis (NASH). 5. Diagnostic approach. 1) Blood chemical analysis]. Nihon Naika Gakkai Zasshi (2006) 0.75
Vitamin E supplementation increases polyunsaturated fatty acids of RBC membrane in HCV-infected patients. Nutrition (2004) 0.75
Endothelium-dependent contraction of rat thoracic aorta induced by gallic acid. Phytother Res (2003) 0.75
Investigation of the structure of cellulose in LiCl/DMAc solution and its gelation behavior by small-angle X-ray scattering measurements. Macromol Biosci (2006) 0.75
Improvement of serum bilirubin levels after venesection in a patient with Dubin-Johnson syndrome and HCV-positive chronic liver disease. J Gastroenterol (2004) 0.75
Two male patients with Wilson's disease treated using trientine and iron reduction therapy. J Gastroenterol Hepatol (2005) 0.75
Preliminary study of spontaneous hepatitis in Long-Evans Cinnamon rats: a blood exchange may improve fetal hepatitis. Nagoya J Med Sci (2010) 0.75
[Preliminary experience of transcatheter hepatic artery embolization using microspheres for polycystic liver disease]. Nihon Jinzo Gakkai Shi (2013) 0.75
Prevalence and outcomes of acute hepatitis B in Okayama, Japan, 2006-2010. Acta Med Okayama (2014) 0.75
Protein kinase Cbeta isoform down-regulates the expression of MDR3 P-glycoprotein in human Chang liver cells. Biochim Biophys Acta (2006) 0.75
Mutation analysis of the multidrug resistance protein 2 (MRP2) gene in a Japanese patient with Dubin-Johnson syndrome. Hepatol Res (2004) 0.75